Abstract
Specific chromosomal deletions sometimes associated with tumours such as retinoblastoma (chromosome 13q14)1 and Wilm's tumour (chromosome 11p13)2 have led to the hypothesis that recessive genes may be involved in tumorigenesis3. This hypothesis is supported by demonstration of allele loss specific for these regions using polymorphic DNA markers4–9 and by the isolation of a complementary DNA clone for the retinoblastoma gene10. A cytogenetic deletion in chromosome 3 (p14–p23) was reported in small-cell lung cancer (SCLC) by Whang-Peng et al11,12. At least one homologue of chromosome 3 was affected in the majority of SCLC tumours; however, the multiple chromosomal changes seen presented the possibility that chromosome 3 was rearranged, not deleted. We used polymorphic DNA probes for chromosome 3p and compared tumour and constitutional genotypes of nine SCLC patients. Our data show loss of alleles of chromosome 3p markers in tumour DNA of all nine patients supporting the hypothesis that this region contributes to tumorigenesis in SCLC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Francke, U. Cytogenet. Cell Genet. 16, 131–134 (1976).
Riccardi, V. M., Sujansky, E., Smith, A. C. & Francke, U. Pediatrics 61, 604–610 (1978).
Knudson, A. G. A. Rev. Genet. 20, 231–251 (1986).
Cavenee, W. K. et al. Nature 305, 779–784 (1983).
Koufos, A. et al. Nature 309, 170–172 (1984).
Orkin, S. H., Goldman, D. S. & Sallan, S. E. Nature 309, 172–174 (1984).
Reeve, A. E. et al. Nature 309, 174–176 (1984).
Fearon, E. R., Vogelstein, B. & Feinberg, A. P. Nature 309, 176–178 (1984).
Glaser, T. et al. Nature 321, 882–887 (1986).
Friend, S. H. et al. Nature 323, 643–646 (1986).
Whang-Peng, J. et al. Cancer Genet. Cytogenet. 6, 119–134 (1982).
Whang-Peng, J. et al. Science 215, 181–182 (1982).
DeMartinville, B., Shafer, M., White, R. & Francke, U. Cancer Genet. Cytogenet. 37, 531–532 (1984).
Gerber, M. J., Miller, Y. E., Drabkin, H. A. & Scoggin, C. H. Cytogenet. Cell. Genet. 42, 72–74 (1986).
Barker, D., Schafer, M. & White, R. Cell 36, 131–138 (1984).
Naylor, S. L., Sakaguchi, A. Y., Barker, D., White, R. & Shows, T. B. Proc. natn. Acad. Sci. U.S.A. 81, 2447–2451 (1984).
Harper, M. E. & Saunders, G. F. Chromosoma 83, 431–439 (1981).
Goode, M. E., vanTuinen, P., Ledbetter, D. H. & Daiger, S. P. Am. J. hum. Genet. 38, 437–446 (1986).
Carritt, B., Welch, H. M. & Parry-Jones, N. J. Am. J. hum. Genet. 38, 428–436 (1986).
Donlon, T. A. & Magenis, R. E. Cytogenet. Cell Genet. 37, 454–455 (1984).
Wurster-Hill, D. H. et al. Cancer Genet. Cytogenet. 13, 303–340 (1984).
Yunis, J. J. Science 221, 227–236 (1983).
Falor, W. H., Ward-Skinner, R. & Wegryn, S. Cancer Genet. Cytogenet. 16, 175–177 (1985).
Buys, C. H. C. M., Van der Veen, A. J. & deZey, L. 8th International Chromosome Conference, Lubeek GFR, 1983.
Seizinger, B. R., Martuza, R. L. & Gusella, J. F. Nature 322, 644–647 (1986).
Fearon, E. R., Feinberg, A. P., Hamilton, S. H. & Vogelstein, B. Nature 318, 377–380 (1985).
Cohen, A. J. et al. New Engl. J. Med. 301, 592–595 (1979).
Pathak, S., Strong, L. C., Ferrell, R. E. & Trindade, A. Science 217, 939–941 (1982).
Pederson, M., Strand, R. & Wang, N. Am. J. hum. Genet. 36, 1095 (1984).
Hansen, M. F. et al. Proc. natn. Acad. Sci. U.S.A. 82, 6216–6220 (1985).
Ibson, J. M. et al. J. Cell Biochem. 33, 267–288 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Naylor, S., Johnson, B., Minna, J. et al. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 329, 451–454 (1987). https://doi.org/10.1038/329451a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/329451a0
This article is cited by
-
Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications
Cancer Gene Therapy (2022)
-
8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification
Experimental & Molecular Medicine (2022)
-
DNA repair genes hOGG1, XRCC1 and ERCC2 polymorphisms and their molecular mapping in breast cancer patients from India
Molecular Biology Reports (2020)
-
Novel strategies for the treatment of small-cell lung carcinoma
Nature Reviews Clinical Oncology (2011)
-
Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer
Oncogene (2008)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
